Welcome to our dedicated page for STANDARD PREMIUM FINANCE HOLDINGS SEC filings (Ticker: SPFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on STANDARD PREMIUM FINANCE HOLDINGS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into STANDARD PREMIUM FINANCE HOLDINGS's regulatory disclosures and financial reporting.
The proxy excerpt explains how stockholders can obtain materials and vote for the Annual Meeting: follow the 12-digit control number at https://www.iproxydirect.com/spfx, return a signed proxy card for receipt by 4:00 p.m. on November 7, 2025, or vote in person (in-person votes supersede prior votes). Alternative requests for paper materials may be made by fax (202-521-3464), telephone (1-866-752-8683), or email (proxy@iproxydirect.com) with the 12-digit notice number. The Compensation Committee discloses it takes material non-public information into account when timing and setting equity awards and states the Company does not time disclosures to affect award value. The filing lists audit-related fee categories showing figures of 2,500 in certain rows and provides detailed beneficial ownership counts and exercisable options for named individuals (for example, Mr. Koppelmann: 806,155 shares plus 10,000 options at $4.95; others include option exercise prices and tenures). The excerpt closes with signatures including Scott Howell, MD; Christian Hoechner; Mark Kutner, MD.